BR112018071493A2 - usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce - Google Patents
usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoceInfo
- Publication number
- BR112018071493A2 BR112018071493A2 BR112018071493-3A BR112018071493A BR112018071493A2 BR 112018071493 A2 BR112018071493 A2 BR 112018071493A2 BR 112018071493 A BR112018071493 A BR 112018071493A BR 112018071493 A2 BR112018071493 A2 BR 112018071493A2
- Authority
- BR
- Brazil
- Prior art keywords
- nutritional composition
- preventing
- ala
- induced
- manufacture
- Prior art date
Links
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 235000016709 nutrition Nutrition 0.000 title abstract 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 title abstract 2
- 230000001149 cognitive effect Effects 0.000 title abstract 2
- 230000007423 decrease Effects 0.000 title abstract 2
- 235000020778 linoleic acid Nutrition 0.000 title abstract 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 title abstract 2
- 230000004766 neurogenesis Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000009286 beneficial effect Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hospice & Palliative Care (AREA)
- Pediatric Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
a invenção refere-se a composições nutricionais que compreendem ácido linoleico (la) e ácido alfa-linolênico (ala) em uma razão, em peso, de la/ala na faixa de 0,1 a 12 que têm um efeito benéfico na prevenção de declínio no funcionamento cognitivo induzido por estresse precoce em um sujeito humano e/ou que têm um efeito benéfico na prevenção da redução na neurogênese induzida por estresse precoce em um sujeito humano.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NLPCT/NL2016/050271 | 2016-04-18 | ||
PCT/NL2016/050271 WO2017183956A1 (en) | 2016-04-18 | 2016-04-18 | Linoleic acid and alpha-linolenic acid for use for reducing early-life stress induced cognitive decline |
EP16188154.5 | 2016-09-09 | ||
EP16188154 | 2016-09-09 | ||
PCT/NL2017/050246 WO2017183970A1 (en) | 2016-04-18 | 2017-04-18 | Linoleic acid and alpha-li nolenic acid for use for reducing early-life stress induced cognitive decline/reduction in neurogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018071493A2 true BR112018071493A2 (pt) | 2019-02-19 |
Family
ID=58639027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018071493-3A BR112018071493A2 (pt) | 2016-04-18 | 2017-04-18 | usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3445353A1 (pt) |
CN (1) | CN109310662A (pt) |
BR (1) | BR112018071493A2 (pt) |
RU (1) | RU2741495C2 (pt) |
WO (1) | WO2017183970A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024121222A1 (en) * | 2022-12-06 | 2024-06-13 | N.V. Nutricia | Infant formula for improving cognitive development |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6596302B2 (en) * | 2000-04-13 | 2003-07-22 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
MXPA05014190A (es) * | 2003-06-24 | 2006-07-03 | Univ Kansas Medical Center | Formula para lactantes. |
DK1800675T3 (da) * | 2005-12-23 | 2011-09-05 | Nutricia Nv | Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens |
RU2444210C2 (ru) * | 2005-12-23 | 2012-03-10 | Н.В. Нютрисиа | Питательные композиции для младенцев, предназначенные для предупреждения ожирения |
WO2009002145A1 (en) * | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
WO2009002166A1 (en) * | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Improving memory in subjects with mini-mental state examination of 24-26 |
AR073485A1 (es) | 2008-09-02 | 2010-11-10 | Nutricia Nv | Composiciones nutricionales con globulos lipidicos de gran tamano |
EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
CN101773223B (zh) * | 2010-02-11 | 2013-01-02 | 圣元营养食品有限公司 | 婴儿食品组合物 |
WO2011115476A1 (en) * | 2010-03-17 | 2011-09-22 | N.V. Nutricia | Infant nutrition for improving fatty acid composition of brain membranes later in life |
JP6067558B2 (ja) * | 2011-06-29 | 2017-01-25 | 日本水産株式会社 | 恐怖記憶の軽減方法 |
RU2689550C1 (ru) * | 2013-12-12 | 2019-05-28 | Нестек С.А. | Искусственные молочные композиции, содержащие полиненасыщенные жирные кислоты (ПНЖК), для содействия здоровому развитию когнитивной функции у младенцев и детей младшего возраста мужского и женского пола |
-
2017
- 2017-04-18 BR BR112018071493-3A patent/BR112018071493A2/pt not_active Application Discontinuation
- 2017-04-18 WO PCT/NL2017/050246 patent/WO2017183970A1/en active Application Filing
- 2017-04-18 RU RU2018140486A patent/RU2741495C2/ru active
- 2017-04-18 CN CN201780037737.2A patent/CN109310662A/zh active Pending
- 2017-04-18 EP EP17719941.1A patent/EP3445353A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
RU2018140486A (ru) | 2020-05-19 |
EP3445353A1 (en) | 2019-02-27 |
CN109310662A (zh) | 2019-02-05 |
RU2018140486A3 (pt) | 2020-07-14 |
WO2017183970A1 (en) | 2017-10-26 |
RU2741495C2 (ru) | 2021-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2021003036A2 (es) | Compuestos de anillo fusionado | |
CO2021005987A2 (es) | Compuestos de anillo fusionado | |
ECSP17043316A (es) | Polvo de coleópteros | |
BR112017018368A2 (pt) | composições contendo rna para o tratamento de doenças tumorais | |
CL2017000201A1 (es) | Composiciones y métodos de uso para tratar trastornos metabólicos | |
CL2017000864A1 (es) | Composiciones y métodos de uso para tratar trastornos metabólicos | |
TR201910765T4 (tr) | Bitkisel hülasaların bir karışımını veya bu bitkilerde mevcut moleküllerin bir karışımını içeren bileşim ve karbonhidrat ve/veya lipit metabolizmasını etkilemek için kullanımı. | |
ECSP17043318A (es) | Composición que contiene quitina y proteínas digeribles | |
BR112017027567A2 (pt) | proteínas de fusão para inibir a angiogênese | |
BR112018003745A2 (pt) | composições que compreendem um composto de urolitina | |
BR112017025339A2 (pt) | composições nutricionais contendo um nível elevado de inositol e usos das mesmas | |
UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
BR112017003346A2 (pt) | derivados de pirazolopiridina, seus usos, e composição farmacêutica | |
BR112017012714A2 (pt) | composição de liberação modificada, método para tratamento ou prevenção de uma doença ou condição, e, método cosmético para reduzir peso corporal. | |
BR112018003780A2 (pt) | composições que compreendem um composto de urolitina | |
BR112018007958A2 (pt) | composições e métodos que usam um polifenol para a saúde musculoesquelética | |
BR112017007375A2 (pt) | composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral | |
BR112016025876A8 (pt) | composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 | |
BR112018009941A8 (pt) | composição reguladora de crescimento vegetal com efeito sinergético | |
BR112018000236A2 (pt) | composições nutricionais e métodos para a promoção do desenvolvimento cognitivo | |
BR112018014590A2 (pt) | formulações/composições compreendendo um inibidor de btk | |
BR112021019262A2 (pt) | Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose | |
BR112017006416A2 (pt) | composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico | |
BR112018000786A2 (pt) | métodos e composições usando bifidobacterium longum para modular a reatividade emocional e tratar ou evitar perturbações subclínicas do estado de humor | |
BR102015012091A8 (pt) | método para a preparação de uma solução de albumina humana, e, composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |